A durable response to savolitinib in a patient with lung adenocarcinoma harboring two novel MET exon 14 skipping sites
Article in Anti-Cancer Drugs (February 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Anti-Cancer Drugs (February 2023)